CDI was strongly featured in an article from Nature about how artificial kidneys and miniaturized dialysis could save millions of lives. Download A PDF Version of the article.
While a kidney transplant is the most exciting way to treat kidney failure, for the 661,000 Americans with kidney failure, approximately 468,000 survive using conventional dialysis machines. This may holdover patients until they can move up the transplant list, or
Every gift to the UW Medicine Center for Dialysis Innovation is vital and helps us fulfill our mission to improve the health and well-being of people with advanced kidney disease initiating and receiving dialysis treatment
- There is an unmet medical need and challenge to dramatically improve dialysis technology and clinical outcomes in dialysis therapy
- Our vision is that future dialysis therapy will be complication free, and restorative of kidney health
- As committed stewards of your gift, we will leverage every gift dollar into multiple dollars supporting innovation dialysis technologies research
- Kidney disease affects over 20 million adults in the US, and is the 9th leading cause of death in the United States
- The only treatments available for patients who progress to End Stage Renal Disease are dialysis or kidney transplant. Millions do not receive these treatments – while only 2 million patients are on dialysis worldwide.
- 460,000 people in the U.S. are on dialysis – comprising a $35 billion industry
- 24% of the U.S. Medicare budget is spent on treating kidney disease
- While on dialysis, the average life expectancy is only 3-5 years, and risks of complications from infections, blood clots, and vascular access failure remain exceedingly high.
- Dialysis technology remains fundamentally unchanged since its inception in 1962, with little governmental or industry incentive for improvement